ResearcherSoochow UniversityNo recent work listed
Jianping Cao
Matched on ORCID iD 0000-0003-0395-8436; OpenAlex author ID A5004173417. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper
Papers 5
- Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo. Co-author DOI 10.3389/fonc.2021.683695↗
- The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells. Last author DOI 10.2147/dddt.s242557↗
- Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-induced DNA damage. Co-author DOI 10.7150/thno.34015↗
- Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway. Co-author DOI 10.1038/onc.2017.401↗
- Role of non-coding RNAs in pancreatic cancer: the bane of the microworld. Last author DOI 10.3748/wjg.v20.i28.9405↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yang Jiao · 2 shared papers, 2019–2021 · strength 0.25
- Qi Zhang · 2 shared papers, 2019–2021 · strength 0.25
- Ying Xu · 2 shared papers, 2019–2021 · strength 0.25
- Xiaohui Xu · 2 shared papers, 2014–2020 · strength 0.15
- Shuyu Zhang · 2 shared papers, 2014–2020 · strength 0.15
- Zhenyu Wang · 1 shared paper, 2020 · strength 0.11
- Yuyang Zhou · 1 shared paper, 2019 · strength 0.10
- Stephen Zhang · 1 shared paper, 2018 · strength 0.07
- Jiao Xue · 1 shared paper, 2018 · strength 0.07
- Junli Wu · 1 shared paper, 2018 · strength 0.07
- Ming Chen · 1 shared paper, 2018 · strength 0.07
- Yiting Tang · 1 shared paper, 2014 · strength 0.04
- Jun Hao · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.